Jan Volavka, MD
- 11Articles
- 27.5KReads
- 1999–2011Active
- 33Collaborators
- 2.6KCitations
About
Jan Volavka, MD, has contributed extensively to research on schizophrenia and schizoaffective disorders, with a focus on the efficacy of antipsychotic medications in managing hostility and treatment-resistant cases. The work includes analyses of specific drugs such as ziprasidone, aripiprazole, olanzapine, clozapine, and quetiapine, as well as investigations into medication adherence, prolactin levels, and the impact of antipsychotics on aggression and substance abuse. Volavka's publications span from 1999 to 2011 and often involve collaboration with notable colleagues in the field.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
